Condition

Locally Advanced Cervical Cancer clinical trials and research

As of November 12, 2026, Find a Trial lists 17 Locally Advanced Cervical Cancer clinical trials that are recruiting, at sites in 21 countries (most in China (11), Mexico (3), United States (2)). 1 was first registered in the last 30 days. By phase: Phase 2 (6), Phase 3 (2), Phase 1 (1), Phase 2/3 (1). The most active sponsors are National Institute of Cancerología (2), Chongqing University Cancer Hospital (2), Tongji Hospital (2). There are also 2 NIH-funded research projects on Locally Advanced Cervical Cancer, with $1.0 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest Locally Advanced Cervical Cancer clinical trials

StudyPhaseWhereStatusRegistered
Iparomlimab/Tuvonralimab with nab-paclitaxel and cisplatin as neoadjuvant therapy for locally advanced cervical cancer Phase 2 Xi'an, Shaanxi Recruiting Oct 15, 2026
Vitamin D Status and Outcomes in Locally Advanced Cervical Cancer treated with chemoradiotherapy — Kragujevac, Šumadija Recruiting Aug 4, 2026
Patient-tailored 3D-printed ARCHITECT applicator for cervical cancer brachytherapy — Rotterdam Recruiting Feb 27, 2026
Nanocrystalline megestrol acetate with chemoradiation for locally advanced cervical cancer Phase 1 Changsha, Hunan Recruiting Jan 14, 2026
Cadonilimab plus cisplatin given before surgery for locally advanced cervical cancer Phase 2 Zhengzhou, Henan Recruiting Aug 5, 2025
Pre-surgery iparomlimab and tuvonralimab with chemotherapy for locally advanced cervical cancer Phase 2 Fuzhou, Fujian Recruiting Jul 8, 2025
Understanding cervical cancer treatment and characteristics in Italy — Bologna, Bologna and 10 other locations Recruiting Jan 13, 2025
Comparing neoadjuvant chemoimmunotherapy and concurrent chemoradiotherapy for locally advanced cervical cancer Phase 2/3 Hefei, Anhui and 11 other locations Recruiting Mar 1, 2024
Neoadjuvant immunochemotherapy for PD-L1-negative locally advanced cervical cancer Phase 2 Hefei, Anhui and 11 other locations Recruiting Mar 1, 2024
Comparing Cisplatin and Gemcitabine with Radiotherapy for Cervical Cancer Phase 3 Mexico City, Mexico City Recruiting Dec 5, 2023

All recruiting trials (17)

NIH-funded research (2)

Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.

Related topics

Cervical CancerNeoadjuvant ChemoimmunotherapyCadonilimabIparomlimabTuvonralimabCachexiaCancer of the PancreasConcurrent ChemoradiotherapyGemcitabineLocally Advanced Cervical CarcinomaLocally Advanced Pancreatic CancerMetastatic Cervical CancerPancreas CancerPancreatic Cancer

Quick answers

How many Locally Advanced Cervical Cancer clinical trials are recruiting right now?

17, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 21 countries. The most sites are in China (11 trials), Mexico (3 trials), United States (2 trials), Italy (2 trials), Netherlands (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 6, Phase 3: 2, Phase 1: 1, Phase 2/3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.